RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA

Clinical trials for RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Gene test could tailor chemo for tough pancreatic cancers

Knowledge-focused Not yet recruiting

This study aims to see if using a genetic test (transcriptomic signature) to choose chemotherapy improves outcomes for people with borderline resectable pancreatic cancer. About 367 participants will receive standard chemotherapy, and researchers will track how long they live wit…

Matched conditions: RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA

Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused

Last updated Jun 17, 2026 05:43 UTC

RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA

Get alerted when new RESECTABLE BORDERLINE PANCREATIC ADENOCARCINOMA trials appear

Gene test could tailor chemo for tough pancreatic cancers